ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

How Precise Diagnostic Tools Support Personalized Bladder Cancer Care

photo

SPONSORED CONTENT -- (StatePoint) Every bladder cancer journey is different, and no single treatment or diagnostic path fits everyone. According to patients who have experienced bladder cancer, the best care for you will depend on your personal situation.

“After experiencing recurring bladder cancer, I learned that understanding my path forward meant looking beyond general statistics and seeking out more precise care based on my individual case,” says Michael F.

A More Complete Picture

Because doctors often tailor treatment decisions, it’s best that the diagnostic procedures they use give them the most complete picture possible. One option your doctor may offer is Blue Light Cystoscopy (BLC), a diagnostic procedure designed to help your urologic surgeon better visualize tumors in your bladder.

BLC involves placing a special imaging agent into the bladder at least one hour before the procedure. During the procedure, the surgeon will examine the bladder lining using regular white light, then switch on a special blue light. The imaging agent causes the tumors to glow bright pink in the special blue light. The enhanced visibility helps define the edges of visible tumors and reveals a certain type of flat, cancerous lesion that can otherwise be difficult to detect.

BLC is currently used during TURBT (transurethral resection of bladder tumor) procedures and can also be used during cystoscopies to monitor progress during surveillance visits. Your doctor might recommend BLC to provide a more detailed view of your bladder and to help gather tissue samples that can provide information that aids in diagnosis and treatment planning. Having a better understanding of the characteristics of your bladder cancer can help your doctor determine or adjust your treatment plan, and choose an appropriate follow-up approach for you.

“Once my doctors began using blue light, it became a standard part of my cystoscopies, allowing them to identify areas of concern that had not been visible before,” says Michael F.

Michael F’s recurring bladder cancer required multiple rounds of treatment, including immunotherapy, chemotherapy and eventually gene therapy. Over the course of his treatments, he underwent 10–11 cystoscopies — most of which utilized BLC to identify suspicious cells that were otherwise undetectable. “With my robust form of cancer, the enhanced cystoscopies were able to reveal suspicious cells that turned out to be pre-cancerous. This helped my care team respond faster and more efficiently,” he says.

Asking About Your Options

Your urologist will consider many factors when recommending diagnostics, and not every tool is right for every bladder cancer case. When discussing your care with your urologic surgeon, here are a few questions you might ask:

1. “Would Blue Light Cystoscopy be helpful in my case?”

2. “What are the options for getting an enhanced view of my bladder?”

3. “How do you personalize care plans for someone with my diagnosis?”

Michael F. often reminds others that statistics are general, not personal, and encourages speaking up when something doesn’t seem right. “Staying informed of your care options, as well as being honest, open and proactive with your care team throughout your bladder cancer journey can help you get precise, personalized care,” he says.

If you are interested in exploring BLC, speak with your urologist. For information about locations that offer BLC, visit https://rebrand.ly/BLClocations.

Every cancer care path is unique

— and so are the tools that may be used along the way. BLC is one diagnostic option your urologic oncologist may use to help visualize your bladder more clearly, and provide timely, tailored treatment.

Sponsored by Photocure, Inc.

*****

Photo Credit: (c) Wavebreakmedia / iStock via Getty Images Plus

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.